drugset / Trial / NCT00665106
Safety and Tolerability of NOVA63035 "Corticosteroid" in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy
Non-randomizedSingle-groupOpen-labelSupportive care
Summary
Evaluation of safety and tolerability of a single injection of NOVA63035 "Corticosteroid" administered at one of four doses in patients with diabetic macular edema (DME) secondary to diabetic retinopathy
Timeline
- Start
- 2008-04
- Primary completion
- 2011-09
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone Palmitate | Other / unclassified | 0.8 % | — |
| Subject | Dexamethasone Palmitate | Other / unclassified | 3.2 % | — |
| Subject | Dexamethasone Palmitate | Other / unclassified | 3.4 % | — |